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Abstract
Introduction—We sought to compare the outcomes of patients with cryptic versus overt shock
treated with an emergency department (ED) based early sepsis resuscitation protocol.
Methods—Pre-planned secondary analysis of a large, multicenter ED-based randomized
controlled trial of early sepsis resuscitation. All subjects were treated with a quantitative
resuscitation protocol in the ED targeting 3 physiological variables: central venous pressure, mean
arterial pressure and either central venous oxygen saturation or lactate clearance. The study
protocol was continued until all endpoints were achieved or a maximum of 6 hours. Outcomes
data of patients who were enrolled with a lactate ≥ 4 mmol/L and normotension (cryptic shock)
were compared to those enrolled with sustained hypotension after fluid challenge (overt shock).
The primary outcome was in-hospital mortality.
Results—A total of 300 subjects were enrolled, 53 in the cryptic shock group and 247 in the
overt shock group. The demographics and baseline characteristics were similar between the
groups. The primary endpoint of in-hospital mortality was observed in 11/53 (21%, 95% CI 11 to
34) in the cryptic shock group and 48/247 (19%, 95% CI 15 to 25) in the overt shock group,
difference of 1% (95% CI −10 to 14; log rank test p=0.81).
Conclusion—Severe sepsis with cryptic shock carries a mortality rate not significantly different
from that of overt septic shock. These data suggest the need for early aggressive screening for and
treatment of patients with an elevated serum lactate in the absence of hypotension.
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Severe sepsis hospitalizations have doubled over the last decade resulting in at least 750,000
persons affected annually in the United States (US).1,2 Estimates suggest that 500,000
patients with severe sepsis are treated annually in US emergency departments (ED).3 The
Surviving Sepsis Campaign international consensus guidelines recommend protocol-driven
treatment that uses quantitative resuscitation for ED patients with septic shock, underscoring
the importance of early identification and treatment of these patients.4 Current consensus
definition of septic shock requires suspicion of infection in the setting of either hypotension
after fluid challenge or vasopressor requirement. However, some patients manifest global
tissue hypoxia, evidenced by an elevated blood lactate ≥ 4mmol/L in the setting of
normotension, a state sometimes referred to as cryptic shock.5–7
Although elevated blood lactate has been previously shown to be a strong predictor of
mortality in various critical care populations 8–10, we are aware of no study to date that has
directly compared the outcomes of patients with severe sepsis who are treated with early
quantitative resuscitation for cryptic shock versus overt shock. In this study we sought to
compare outcomes of consecutive, prospectively collected patients presenting to three US
EDs with severe sepsis and treated with an early quantitative resuscitation protocol for
cryptic shock versus overt shock.
Methods
Study Design
We conducted a preplanned secondary analysis of a recently completed prospective, parallel
group, non-blinded randomized clinical trial designed to assess the non-inferiority of lactate
clearance versus central venous oxygen saturation (ScvO2) as the protocol endpoint that
evaluated the adequacy of oxygen delivery during ED based early quantitative resuscitation
of sepsis.11 The trial was registered on Clinicatrials.gov identifier NCT00372502.
The trial took place from January 2007 to January 2009 at Carolinas Medical Center,
Charlotte, NC, Beth Israel Deaconess Medical Center, Boston, MA, and Cooper University
Hospital, Camden, NJ, all of which are large, urban, tertiary care hospitals staffed by
emergency medicine resident physicians supervised by board certified emergency medicine
attending physicians. The study was approved by the Institutional Review Board at each
institution (090602A) and all participants or their surrogate provided written informed
consent for participation.
Consecutive patients presenting to one of the participating EDs with severe sepsis or septic
shock were eligible for enrollment if they were older than 17 years, had confirmed or
suspected infection, two or more systemic inflammatory response criteria12, and
hypoperfusion evidenced by either a systolic blood pressure (SBP) lower than 90mmHg
after a minimum of 20 mL/kg rapid volume challenge or a blood lactate concentration of at
least 4 mmol/L. The criteria for exclusion from the study were pregnancy, any primary
diagnosis other than sepsis, suspected requirement for immediate surgery within 6 hours of
diagnosis, an absolute contraindication to chest or neck central venous catheterization,
cardiopulmonary resuscitation, and advanced directive orders that would restrict the study
procedure.
After enrollment patients were randomly assigned to 1 of 2 groups. Each group received
structured quantitative resuscitation while in the ED (the resuscitation protocol can be found
at:
http://jama.ama-assn.org/content/suppl/2010/02/18/303.8.739.DC1/
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jwe05013_02_24_2010.pdf). The ScvO2 group (N=150) was resuscitated by sequentially
providing therapy needed to meet thresholds of central venous pressure, followed by mean
arterial pressure, and then ScvO2 as originally described by Rivers et al.13 The lactate
clearance group (N=150) had similarly targeted thresholds in central venous pressure,
followed by mean arterial pressure, and then lactate clearance (defined as a decrease in
serum lactate of at least 10% over 2 hours) instead of ScvO2 to assess for adequate oxygen
delivery. The study protocol was continued until all endpoints were achieved or a maximum
of 6 hours. The published results of this study showed a 6% (95% confidence intervals −3 to
14%) in-hospital mortality difference between the two study groups, confirming the primary
hypothesis of non-inferiority.14
Data Analysis and Outcomes
The primary outcome was in-hospital mortality. We compared outcomes data of patients
who qualified for enrollment with cryptic shock, defined as a lactate >4 mmol/L and
normotension (SBP at least 90 mm Hg) to those that qualified with overt shock, defined as
hypotension (SBP lower than 90mmHg) after a minimum of 20 mL/kg rapid volume
challenge with Kaplan-Meier survival estimates and generalized Wilcoxon (Peto-Prentice)
log rank test. Baseline characteristics and co-interventions were compared using chi-square
or Fisher exact tests for categorical data, and t-tests or Mann-Whitney-U tests for continuous
data, as appropriate. Secondary outcomes included ICU and hospital length of stay and in-
hospital hospital complications.
Odds ratios (ORs) were calculated to determine independent predictors of in-hospital
mortality by using logistic regression with bootstrap correction for 95% confidence
intervals. Six variables (age, sequential organ failure assessment (SOFA) score, initial
lactate, pulmonary infection, presence of end stage renal disease, and group assignment
(overt or cyptic shock)) were entered into the regression analysis. Continuous data are
presented as means and standard deviations or medians and interquartile ranges. Categorical
data are presented as proportions with 95% confidence intervals (CI). All statistical tests
were two sided with p<0.05 considered significant. All data were analyzed using StatsDirect
statistical software (StatsDirect 2.7.7, Cheshire, England).
Results
A total of 300 subjects were enrolled, 53 in the cryptic shock group and 247 in the overt
shock group (Figure 1). Baseline demographics and baseline characteristics are shown in
Table 1. Patients with diabetes mellitus, end-stage renal disease, and intra-abdominal
infections were significantly more likely to present with cryptic shock. Blood cultures were
positive in 115/300 (38%) of patients with 69/115 (60%) being gram positive organisms and
46/115 (40%) being gram negative organisms. Baseline physiological and severity of illness
characteristics are shown in Table 2. As expected, patients in the cryptic shock group had a
significantly higher baseline SBP and a significantly higher blood lactate concentration.
There were no differences in co-interventions administered between the cryptic and overt
shock groups (Table 3). A total of 43% (23/53) of the patients in the cryptic shock group and
75% (184/247) of patients in the overt shock group required continuous vasopressor infusion
at some point during the hospitalization. There was an equal proportion of subjects
randomized to the interventional (lactate clearance) arm in both the cryptic shock (27/53,
51%) and overt shock (123/247, 50%) groups and there were no differences in the
resuscitation goals achieved between the groups (Table 4).
The primary outcome of in-hospital mortality was observed in 11/53 (21%, 95% CI 11 to
34) of patients in the cryptic shock group compared with 48/247 (19%, 95% CI 15 to 25) in
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the overt shock group, difference of 1% (95% CI −10 to 14). Figure 2 shows the Kaplan-
Meier survival curve for the two groups. There was no significant difference in survival
between the groups, log rank test p = 0.81. Additionally, we found no difference in ICU or
hospital length of stay or complications between the groups (Table 5). The adjusted multiple
logistic regression analysis results confirmed SOFA score as the only independent predictor
of mortality (OR 1.1, 95% confidence interval 1.0 to 1.2). Of note, the logistic regression
results support the results of our bivariate analysis by confirming that overt shock was not an
independent predictor of mortality (OR 0.5, 95% confidence intervals 0.2 to 1.1). The model
showed good fit, Hosmer-Lemeshow test p=0.76.
Discussion
In this report we document the outcome of patients with cryptic septic shock who were
treated with early quantitative resuscitation as compared to patients with overt septic shock.
Our findings indicate that patients who qualify for early protocolized sepsis resuscitation
with cryptic shock, defined as a lactate measurement ≥ 4 mmol/L and SBP of at least 90 mm
Hg, have an in-hospital mortality rate (21%) that is not different than patients who qualify
with overt shock (19%). These data highlight the need to screen patients for signs of occult
hypoperfusion, and given the high mortality rate associated with an elevated serum lactate,
also suggest that patients with biochemical evidence of inadequate oxygen delivery despite
normal blood pressure should be included in early sepsis resuscitation pathways.
Measurement of serum lactate is an accepted method of assessing for global tissue hypoxia,
and its prognostic value in various populations has been described.9,15,16 Retrospective16
and prospective studies6 of heterogenous ED populations with suspected infection have
suggested that elevated serum lactate in the setting of normotension, or cryptic shock, carries
a worse prognosis than a normal serum lactate. The present study complements these
previous investigations by documenting equivalent outcomes of patients with cryptic septic
shock treated with early aggressive resuscitation as compared to patients with overt septic
shock. It is important to note that a variety of lactate cutoffs have been reported in the
literature as abnormal, and that dichotomizing the lactate into normal or abnormal may
significantly reduce the predictive value of the test.16 However, for the purposes of this
study, a lactate of >4 mmol/L was considered the threshold for cryptic shock based on the
original, and most commonly used inclusion criteria for early goal-directed therapy.13
A clinician could dismiss an elevated serum lactate in the setting of hemodynamic stability
as being a less acutely ill patient than one presenting with overt hypotension after volume
challenge. This view may result in a tendency to withhold certain early interventions, such
as early quantitative resuscitation. However, the clinical data from the present study do not
support a clear distinction between these two groups and most importantly, both have the
same high risk of death. We interpret these data to indicate that early, aggressive
resuscitation protocols available for patients in overt shock should be strongly considered
for patients in cryptic shock.
One of the strengths of our study is that both groups were treated with an early aggressive
resuscitation protocol targeting physiological endpoints, which is an important difference
between this study and previous cohort studies on this topic.6,16 Additionally, in a general
sense enrollment in a controlled clinical trial with specific inclusion criteria results in a more
homogenous patient population than might be seen in registries or observational studies.
Thus our study enhances the current literature by demonstrating that patients presenting to
the ED with severe sepsis who are identified as candidates for and are treated with an early
quantitative resuscitation protocol, inclusion by elevation of serum lactate of at least 4.0
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mmol/L with normotension caries an equal risk of hospital death as overt shock, despite
equally aggressive therapy.
This report has several limitations that should be noted. First, although we had robust
mechanisms at each center to ensure as close to a consecutive sample as was possible, it
remains possible that some of the patients with elevated lactate were not enrolled. Second,
this study was conducted at institutions that had established ED based quantitative
resuscitation programs for sepsis prior to initiation of the study.17–19 Therefore, our results
may not be generalizable to centers that do not routinely perform early quantitative
resuscitation. Third, in the parent study patients were enrolled into one of two treatment
protocols, which could potentially affect outcome. However, in the present analysis there
were an equal proportion of patients in the cryptic shock and overt shock groups that were
assigned to each treatment group and achievement of resuscitation goals were similar in both
the overt and cryptic shock groups. Therefore we do not suspect significant interaction
between the trial treatment and the shock group.
Conclusion
In this analysis, we document that patients presenting with cryptic septic shock have a
mortality rate that is not significantly different from that of overt septic shock. These data
suggest the need for early aggressive screening for and treatment of patients with evidence
of global tissue hypoxia in the absence of hypotension.
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Kaplan-Meier survival curves for overt shock and cryptic shock groups
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Table 1






Age* 65 (55,74) 61 (49,71) 0.14
Race (%)
   Caucasian 28 (53) 136 (55) 0.89
   Black American 18 (34) 84 (34)
   Other 7 (13) 27 (11)
Sex (%)
   Male 26 (49) 137 (55) 0.49
   Female 27 (51) 110 (45)
Co-morbidities (%)
   Diabetes mellitus 26 (49) 76 (31) 0.02
   Chronic obstructive pulmonary disease 9 (17) 41 (17) 0.99
   Human immunodeficiency virus 2 (4) 23 (21) 0.27
   End stage renal disease 10 (19) 19 (8) 0.03
   Active malignancy 13 (25) 61 (25) 0.99
   Organ transplant 3 (6) 8 (3) 0.42
   Indwelling vascular line 5 (9) 38 (15) 0.36
   Nursing home resident 7 (13) 49 (20) 0.35
   Do not resuscitate 2 (4) 7 (3) 0.66
Disease severity*,+
   SAPS II score 43 (32,54) 42 (31,55) 0.94
   SOFA score 6 (4,9) 6 (4,9) 0.44
   MEDS score 11 (9,12) 11 (8,14) 0.62
Suspected Source of Infection (%)
   Pulmonary 10 (19) 92 (37) 0.02
   Urinary tract 13 (25) 66 (27)
   Intra-abdominal 16 (30) 33 (13)
   Skin/soft tissue 7 (13) 28 (11)
   Blood 1 (2) 10 (4)
   Unknown 6 (11) 18 (7)
Abbreviations: CS - cryptic shock; OS - overt shock; SAPS - simple acute physiology score; SOFA - Sequential Organ Failure Assessment; MEDS




Disease severity scores calculated at time of enrollment













Puskarich et al. Page 10
Table 2
Physiological, severity of illness, and laboratory measurements.
Variable* Initial Value
Systolic blood pressure (mm Hg)
   Cryptic shock group 108 (92, 126)
   Overt shock group 85 (77, 98)
   P value <0.01
Heart rate (beats/min)
   Cryptic shock group 114 (91, 128)
   Overt shock group 102 (85, 120)
   P value 0.04
Central venous pressure (mm Hg)
   Cryptic shock group 9 (5, 14)
   Overt shock group 10 (7, 14)
   P value 0.33
Central venous oxygen saturation (%)
   Cryptic shock group 79 (65, 84)
   Overt shock group 78 (64, 87)
   P value 0.67
Lactate level (mmol/L)
   Cryptic shock group 5.8 (4.5, 7.5)
   Overt shock group 2.6 (1.4,4.3)
   P value <0.01
Respiratory Rate (breaths/min)
   Cryptic shock group 26 (20, 32)
   Overt shock group 22 (18,28)
   P value 0.01
Glasgow coma scale
   Cryptic shock group 15 (13,15)
   Overt shock group 15 (14,15)
   P value 0.62
*
Median (IQR)
Abbreviations: mm Hg - millimeters of mercury; min - minutes; mmol - millimoles; L - liter
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Table 3
Administered treatments and resuscitation endpoints.
Intervention Value
Total crystalloid volume, 0–6 hrs (L)*
   CS group 4.0 (2.1,5.6)
   OS group 4.6 (2.8, 6.0)
   P value 0.17
Corticosteroids, 0–6 hrs n, (%)
   CS group 5 (9)
   OS group    39 (16)
   P value 0.33
Time to initial antibiotics (min)*,+
   CS group 116 (70, 162)
   OS group 113 (62, 175)
   P value 0.63
Mechanical ventilation n, (%)
   CS group 19 (32)
   OS group 77 (31)
   P value 0.61
Activated Protein C n, (%)
   CS group 1 (2)
   OS group 4 (2)
   P value 0.99




Time from triage to initiation of antibiotics





















Central venous pressure ≥ 8 mmHg (%) 49 (92) 220 (89) 0.46
Mean arterial pressure ≥ 65 mmHg (%) 50 (94) 233 (94) 0.99
Central venous oxygen saturation ≥ 70% (%)
or Lactate Clearance ≥ 10% (%)*
51 (96) 237 (97) 0.69
Abbreviations: CS - cryptic shock; OS - overt shock; mm Hg - millimeters of mercury
*
Depending on protocol group assignment
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Table 5






In-hospital mortality (%)* 11 (21) 48 (19) 0.82
Length of Stay+
   ICU 3.3 (2, 6.2) 3.0 (1.7,6.5) 0.80
   Hospital 8 (4.7, 14) 8 (5,13.9) 0.84
Hospital complications (%)
   Multiple organ failure 15 (28) 54 (22) 0.41
   Care withdrawn 9 (17) 28 (11) 0.39





Resuscitation. Author manuscript; available in PMC 2012 October 1.
